Overview Evaluating of the Effect of Fingolimod With Fish Oil on Relapsing-Remitting Multiple Sclerosis Patients Status: Completed Trial end date: 2016-10-01 Target enrollment: Participant gender: Summary This study evaluates the effect of adding fish oil to Fingolimod on some serum cytokines in patients with Relapsing-Remitting Multiple Sclerosis. Phase: Phase 2/Phase 3 Details Lead Sponsor: Isfahan University of Medical SciencesCollaborator: Shiraz University of Medical SciencesTreatments: Fingolimod Hydrochloride